NCT01745627已完成不适用
755nm Alex Laser for Treatment of Pigmented and Vascular Lesions and Scars
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 43
- 试验地点
- 1
- 主要终点
- Clearance Based on Photographic Scale
研究概览
简要总结
Evaluation of the safety and efficacy of the 755nm Alex laser for the treatment of benign pigmented and vascular lesions and scars
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy male or female subjects between 18 and 85 years of age.
- •Subjects with Fitzpatrick skin types I to VI.
- •Subjects who have unwanted pigmented lesions, vascular lesions, striae and/or hypertrophic or atrophic scars
- •Subject who are willing to consent to participate in the study.
- •4.2 Exclusion Criteria
- •Subject who will not be photographed or who will not cooperate with the post treatment care and follow up schedule
- •Hypersensitive to light exposure.
- •Active localized or systemic infections.
- •Taking medication for which sunlight is a contraindication.
- •History of squamous cell carcinoma or melanoma.
- •History of keloid scarring.
- •Use of oral isotretinoin (Accutane®) within 12 months of initial treatment or during the course of the study. Note: Skin must regain its normal degree of moisture prior to treatment.
- •Prior treatment with laser or other devices in treatment area within 3 months
- •History of immunosuppression/immune deficiency disorders (including HIV infection or AIDS) or use of immunosuppressive medications.
- •Subjects who are pregnant, have been pregnant within the last 3 months, are currently breast feeding or are planning a pregnancy within the study period.
- •Subjects that the physician determines ineligible based on standard of care treatment.
排除标准
- 未提供
结局指标
主要结局
Clearance Based on Photographic Scale
时间窗: 3 months post last treatment
This scale ranges from 0 to 3, where 0 is 0-25% clearance, 1 is 26-50% clearance, 2 is 51-75% clearance and 3 is 76-100% clearance. The baseline picture was compared to a photograph taken at the follow up visit. The number of patients that fell into each category was recorded.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Evaluation of the 755nm Alexandrite for the Treatment of Epidermal and Dermal Pigmented LesionsDermal and Epidermal Pigmented LesionsNCT01754233Cynosure, Inc.6
撤回
不适用
Clinical Evaluation of 755nm Alexandrite Laser Versus Nanosecond 755nm AlexandriteTattoosNCT01811017Cynosure, Inc.
已完成
不适用
Evaluation of the 755nm Alexandrite Laser for the Treatment of TattoosTattoosNCT01754207Cynosure, Inc.20
已完成
不适用
Evaluation of the 755nm Alexandrite Laser for Skin Toning and Epidermal Pigmented Lesions in Asian Skin TypesEpidermal Pigmented LesionsSkin ToningNCT01754246Cynosure, Inc.20
已完成
4 期
The efficacy and safety of 755 nm picosecond laser for the treatment of lip hyperpigmentation in asians: a pilot studyMinimal local side effects such as redness, swollen and skin irritation may occur. These could be resolved within a few days.Local side effectTCTR20210129006Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University20